| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2018.03.033 |
| P698 | PubMed publication ID | 29598897 |
| P50 | author | Nicola Baldini | Q37828626 |
| Pierre Layrolle | Q38360448 | ||
| Markus Rojewski | Q54963139 | ||
| Massimo Dominici | Q56849926 | ||
| Nathalie Chevallier | Q57039321 | ||
| Enrique Gómez-Barrena | Q57203030 | ||
| Charles-Henri Flouzat Lachaniette | Q82179752 | ||
| P2093 | author name string | Markus Huber-Lang | |
| Hubert Schrezenmeier | |||
| Cristina Avendaño-Solá | |||
| Davide Maria Donati | |||
| Philippe Hernigou | |||
| José Cordero-Ampuero | |||
| Florian Gebhard | |||
| Philippe Rosset | |||
| Rosaria Giordano | |||
| Christian Ehrnthaller | |||
| Tiziana Montemurro | |||
| Elena Veronesi | |||
| Eduardo García-Rey | |||
| Gabriela Ciapetti | |||
| Sandrine Fleury | |||
| Carmen Panaitescu | |||
| Ramin Lotfi | |||
| Luc Sensebé | |||
| Julien Stanovici | |||
| Rosa M Gonzalo-Daganzo | |||
| Helène Rouard | |||
| José-Rafael Cabrera | |||
| Juan Carlos Rubio-Suárez | |||
| Manuel-Nicolás Fernandez | |||
| Norma Padilla-Eguiluz | |||
| P304 | page(s) | 100-108 | |
| P577 | publication date | 2018-03-19 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial | |
| P478 | volume | 196 |
| Q100455005 | Analysis of cell-biomaterial interaction through cellular bridge formation in the interface between hGMSCs and CaP bioceramics |
| Q58702583 | Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration |
| Q89967410 | Bioactivity of Biphasic Calcium Phosphate Granules, the Control of a Needle-Like Apatite Layer Formation for Further Medical Device Developments |
| Q55024163 | Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. |
| Q91949725 | Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review |
| Q92999530 | Exosomes in the Repair of Bone Defects: Next-Generation Therapeutic Tools for the Treatment of Nonunion |
| Q92128783 | Genetically Engineered-MSC Therapies for Non-unions, Delayed Unions and Critical-size Bone Defects |
| Q57178280 | History of concentrated or expanded mesenchymal stem cells for hip osteonecrosis: is there a target number for osteonecrosis repair? |
| Q64084531 | Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration |
| Q92001797 | Inflammatory response of mesenchymal stromal cells after in vivo exposure with selected trauma-related factors and polytrauma serum |
| Q91899785 | Mesenchymal Stromal Cell-Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles |
| Q89967502 | Reconstruction of Large Skeletal Defects: Current Clinical Therapeutic Strategies and Future Directions Using 3D Printing |
| Q93270537 | Regeneration of segmental defects in metatarsus of sheep with vascularized and customized 3D-printed calcium phosphate scaffolds |
| Q92188147 | Tobacco and bone fractures: A review of the facts and issues that every orthopaedic surgeon should know |
Search more.